SCHEMBL7288458

SCHEMBL7288458

O=C(O)c1c(Cl)ccc(OCc2ccccc2)c1Cl

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLCN2 P51788 2/20 0.60
CHRM4 P08173 1/20 0.60
CHRM3 P20309 1/20 0.60
MRGPRX4 Q96LA9 7/20 0.58
HPGD P15428 3/20 0.54
RXRA P19793 1/20 0.54
RXRB P28702 1/20 0.54
PTGER1 P34995 2/20 0.50
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
MEN1 O00255 1/20 0.50
MITF O75030 1/20 0.50
TP53 P04637 1/20 0.50
XBP1 P17861 1/20 0.50
NFKB1 P19838 1/20 0.50
NFKB2 Q00653 1/20 0.50
KMT2A Q03164 1/20 0.50
RELA Q04206 1/20 0.50
FOLH1 Q04609 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10729722 0.88 CLCN2 (0.54) CLCN2CHRM4CHRM3MRGPRX4HPGD
SCHEMBL7281267 0.85 CLCN2 (0.55) CLCN2CHRM4CHRM3MRGPRX4HPGD
SCHEMBL1495326 0.85 MRGPRX4 (0.54) CLCN2CHRM4CHRM3MRGPRX4HPGD
SCHEMBL7967408 0.79 CLCN2 (0.53) CLCN2CHRM4CHRM3MRGPRX4HPGD
SCHEMBL14829902 0.77 MRGPRX4 (0.48) CLCN2CHRM4CHRM3MRGPRX4HPGD
SCHEMBL8204822 0.76 FOLH1 (0.69) MRGPRX4HPGDRXRARXRBPTGER1
SCHEMBL27977297 0.76 CLCN2 (0.61) CLCN2CHRM4CHRM3MRGPRX4HPGD
SCHEMBL7311890 0.76 CLCN2 (0.51) CLCN2CHRM4CHRM3MRGPRX4HPGD
SCHEMBL1843931 0.76 MEN1 (0.56) MRGPRX4HPGDRXRARXRBPTGER1
SCHEMBL31177876 0.76 MCL1 (0.61) CLCN2CHRM4CHRM3MRGPRX4HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5597841-A 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof STERLING WINTHROP, INC. (US) 1997-01-28 US disclosed
EP-0594257-B1 2-Saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof STERLING WINTHROP INC (US) 1996-07-10 EP disclosed
US-5512589-A TREATING DEGENERATIVE DISEASES STERLING WINTHROP INC. (US) 1996-04-30 US disclosed
EP-0594257-A1 2-Saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof STERLING WINTHROP INC. (US) 1994-04-27 EP disclosed
US-5306818-A Treating degenerative diseases such as emphysema, rheumatoid arthritis and pancreatitis STERLING WINTHROP INC. (US) 1994-04-26 US disclosed
US-5250696-A Treatment of degenerative diseases STERLING WINTHROP INC. (US) 1993-10-05 US disclosed
US-5128339-A Emphysema, rheumatoid arthritis, pancreatitis STERLING WINTHROP INC. (US) 1992-07-07 US disclosed
EP-0483928-A1 2-Saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use STERLING WINTHROP INC. (US) 1992-05-06 EP disclosed
US-4704401-A HYPOTENSIVE AGENTS RORER PHARMACEUTICAL CORPORATION (US) 1987-11-03 US disclosed
US-4487779-A HYPOTENSIVE AGENTS WILLIAM H. RORER, INC. (US) 1984-12-11 US disclosed